target for the development of novel therapeutics against AIDS. Significant efforts have been devoted to the identification of IN inhibitors using various methods. In this context, through virtual screening of the NCI database and structure-based drug design strategies, we identified several pharmacophoric fragments and incorporated them on various aromatic or heteroaromatic rings. In addition, we designed and synthesized a series of 5aryl(heteroaryl)-isoxazole-3-carboxylic acids as biological isosteric analogues of β-diketo acid containing inhibitors of HIV-1 IN and their derivatives. Further computational docking studies were performed to investigate the mode of interactions of the most active ligands with the IN active site.
Integration of viral DNA into host cell chromosomal DNA to form a provirus is an essential step in the viral life cycle (Brown, 1998) . This process is mediated by integrase (IN), a 32 kDa viral enzyme, which catalyses two coordinated biochemical steps (Asante-Appiah et al., 1997 Bushman et al., 1991) . Following reverse transcription in the cytoplasm of infected cells, IN first cleaves two nucleotides from the 3′-ends of the viral long-terminal repeats ('3′-processing'). In the second step, after subsequent migration to the nucleus as a part of a large nucleoprotein complex, IN catalyses the insertion of the resulting shortened strands into a host chromosome by a direct transesterification reaction ('strand transfer'). Because IN does not have a human homologue, it is considered a promising target for the development of new antiretroviral drugs and significant efforts have been devoted to identifying IN inhibitors Neamati, 2001; Neamati et al., 2000; d'Angelo et al., 2001; De Clercq, 2000; Johnson et al., 2004) .
In recent years a plethora of IN inhibitors were identified by systematic screening of natural and synthetic products against purified enzyme (Neamati, 2002; Neamati et al., 2001; Chen et al., 2002; Dayam et al., 2003) . In particular, a class of compounds bearing a βdiketo acid moiety was independently discovered by the scientists from Shionogi & Co. and Merck as selective IN inhibitors (the structures of some representative compounds are shown in Figure 1 ; Hazuda et al., 2000; Wai et al., 2000; Anthony, 2004; . Several potent analogues were identified and two compounds, S-1360 (Shionogi & Co. Ltd; Billich, 2003) and L-870,810 (Merck & Co. Inc.; Hazuda et al., 2004) , are undergoing HIV-1 clinical trials.
In general, searching for IN inhibitors has involved testing compounds that inhibit other enzymes with similar mechanisms, conducting structure-activity relationships studies on known active compounds, performing database searches using pharmacophore models and highthroughput docking or random screening . In particular, three-dimensional structural database searching was successfully used to generate numerous lead compounds Neamati et al., , 1998 Hong et al., 1997 Hong et al., , 1998 Chen et al., 2000; Makhija et al., 2004) .
The aim of this work was to identify novel and/or unified pharmacophores required for activity in order to be implemented in potential lead compounds. Using the crystal structure of 5CITEP-IN complex (Goldgur et al., 1999) , we performed a computational 3D search in the nonproprietary, open part of the National Cancer Institute database (Milne et al., 1994) to identify possible bioisosteres. Several structural platforms with potential as HIV-1 IN inhibitors were selected and their pharmacophoric fragments ( Figure 2 ) incorporated into aromatic or heteroaromatic frameworks to give the general structures [I-VII]. Thus, target compounds were synthesized to evaluate their predicted potential activities. In order to obtain a consistent set of compounds, a series of derivatives of structure [I], [II] and [VI] were also prepared.
Starting from the observation that the diketo acid functionality is not only responsible for antiviral activity, but also (unfortunately) contributes to cytotoxicity (Melek et al., 2002) , we thought that replacing the diketo group with a pertinent bioisostere (Patani et al., 1996; Lipinski, 1986) endowed with reduced cytotoxicity was of paramount importance for discovering drugs targeting IN. In this context, as an extension of this work, we designed novel compounds by incorporating 1,3-diketo moiety (DKA) into a constrained isoxazole ring [VIII] and synthesized a series of 5-aryl(heteroaryl)-isoxazole-3-carboxylic acids [VIIIa-e] ( Figure 3A ). In addition, some modifications to the isoxazole framework were performed in order to establish a coherent structure-activity relationship among these compounds. In particular, we fixed the isoxazole ring into a coplanar tricyclic system and replaced the carboxylic function with an electron-donating group such as methyl to obtain compounds [VIIIf ] and [VIIIg], respectively ( Figure 3B ). In this study, we present the design, synthesis and anti-IN activity of compounds [I-VIII] using a soluble mutant (F185KC280S). Moreover, we discuss the results of docking studies performed to determine the mode of binding between two of the more active compounds, [IId] and [VIa], and some of the amino acid residues of the IN catalytic site.
Materials and methods

Chemistry
Anhydrous solvents and all reagents were purchased from Aldrich, Merck or Carlo Erba. Anhydrous diethyl ether was obtained by distillation from Na/benzophenone under nitrogen. All reactions involving air-or moisture-sensitive compounds were performed under nitrogen atmosphere using oven-dried glassware and syringe septa techniques to transfer solutions. Melting points (mp) were determined using an electrothermal melting point or a Köfler apparatus and are uncorrected. Infrared (IR) spectra were recorded as thin films or nujol mulls on NaCl plates with a Perkin-Elmer 781 IR spectrophotometer and are expressed in v (cm -1 ). Nuclear magnetic resonance ( 1 H-NMR, 13 C-NMR, NOE difference and NOESY) spectra were determined in CDCl 3 , DMSO or CDCl 3 /DMSO (in ratio 3:1) and were recorded on a Varian . Chemical shifts (δ scale) are reported in parts per million (ppm) downfield from tetramethylsilane (TMS) used as an internal standard. Splitting patterns are designated as follows: s, singlet; d, doublet; t, triplet; q, quadruplet; m, multiplet; brs, broad singlet; dd, double doublet. The assignment of changeable protons (OH and NH) was confirmed by the addition of D 2 O. Analytical thin-layer chromatography (TLC) was done on Merck silica gel F-254 plates. For flash chromatography, Merck Silica gel 60 was used with a particle size 0.040-0.063 mm (230-400 mesh ASTM). Elemental analyses were performed on a Perkin-Elmer 2400 spectrometer at Laboratorio di Microanalisi, Dipartimento di Chimica, Università di Sassari (Italy), and were within ±0.4% of the theoretical values.
General procedure for the preparation of (2Z)hydroxy (2-oxo-1,2-dihydro-3H-indol-3-ylidene) 11.51 (brs, 1H, NH), 7.96 (d, 1H, 7.25 (t, 1H, 2H, 1H, COOH) . GC\MS m/z 205 (M + ). Anal. Calc. for C 10 H 7 NO 4 : C, 58.54; H, 3.44; N, 6.83. Found: C, 58.58; H, 3.47; N, 6.80. (2Z)-hydroxy (1-methyl-2-oxo-1,2-dihydro-3H-indol-3ylidene) , 60.27; H, 4.14; N, 6.39. Found: C, 60.41; H, 4.01; N, 16 H 11 NO 4 : C, 68.32; H, 3.94; N, 4.98. Found: C, 68.57; H, 3.69; N, 5.14. General procedure for the preparation of methyl , 60.27; H, 4.14; N, 6.39. Found: C, 60.39; H, 4.05; N, 6.48 .
Methyl (2Z)-hydroxy acetate [Ib] (Long et al., 1978) . Yield= 31%; mp=97-99°C; IR (nujol) v cm -1 =1610 (C=O, amide), 1650 (C=O, ester), 2375 (OH). 1 12 H 11 NO 4 : C, 61.80; H, 4.75; N, 6.01. Found: C, 61.91; H, 4.50; N, 5.83 . were mixed and introduced into a round-bottomed flask when the internal temperature reached 180-190°C. Heating was kept for 10 min. Melted mass was slightly cooled at room temperature and immediately worked up with crushed ice and 1N HCl. The brown product was washed with water and purified by EtOH recrystallization (for [3b]) or by flash chromatography using ethyl acetate as eluent (for [3c]). (Hennessy et al., 2003) . Yield=28%; mp=87-89°C; IR (nujol) v cm -1 = 1690 (C=O amide). 1 H-NMR (CDCl 3 ) δ 7.26 (t, 2H, Ar-H), 7.04 (t, 1H, Ar-H), 6.82 (d, 1H, Ar-H), 3.53 (s, 2H, CH 2 ), 3.21(s, 3H, N-CH 3 ). GC\MS m/z 147 (M + ). (Sarges et al., 1989) . Yield=56%; mp=116-118°C; IR (nujol) v cm -1 =1710 (C=O amide). 1 H-NMR (CDCl 3 ) δ 7.68-7.05 (m, 8H, Ar-H), 6.79 (d, 1H, Ar-H), 3.73 (s, 2H, CH 2 ). GC\MS m/z 209 (M + ).
1-methyl-1,3-dihydro-2H-indol-2-one [3b]
1-phenyl-1,3-dihydro-2H-indol-2-one [3c]
Preparation of 2-chloro-N-methyl-N-phenylacetamide [2b] and 2-chloro-N,N-diphenylacetamide [2c].
A solution of the appropriate N-phenylamine [1b] and [1c] (5 mmol) in anhydrous toluene (20 ml) and chloroacetylchloride (2 eq) was refluxed for 1-2 h under nitrogen atmosphere. Then the mixture was cooled and solvent removed in vacuo. The residue was recrystallized from water (for [2b]) or from ethanol (for [2c]). (Chupp et al., 1967) . Yield=93%; mp=160-161°C; IR (nujol) v cm -1 =1660 (C=O amide). 1 H-NMR (CDCl 3 ) δ 8.33 (s, 3H, N-CH 3 ), 7.28-7.17 (m, 3H, Ar-H), 7.25 (d, 2H, Ar-H), 3.86 (s, 2H, CH 2 ). GC\MS m/z 183 (M + ). (Sarges et al., 1989) . Yield=78%; mp=115-117°C; IR (nujol) v cm -1 = 1665 (C=O amide). 1 H-NMR (CDCl 3 ) δ 7.50-7.26 (m, 10H, Ar-H), 4.03 (s, 2H, CH 2 ). GC\MS m/z 245 (M + ). Then water was added, the mixture was acidified with 2N HCl and the solution was extracted with diethyl ether. Finally, the organic layer was washed with water, dried and concentrated in vacuo. The residue was purified by silica gel flash column chromatography (eluents petroleum ether-ethyl acetate 6:4). The orange solid obtained was recrystallized from ethanol to provide the desired [IIa-IIc]. , 5.67; N, 9.85. Found: C, 67.72; H, 5.84; N, 9.61 . , 5.24; N, 8.09. Found: C, 72.66; H, 5.11; N, 7.85 . , 4.70; N, 7.69. Found: C, 69.45; H, 4.61; N, 7.77 .
2-chloro-N-methyl-N-phenylacetamide [2b]
2-chloro-N,N-diphenylacetamide [2c]
Preparation of ethyl
[2E]-3-cyano-3-(1-alkyl-1H-indol- 3-yl)-2-hydroxyacrylates [IIa-IIc].Ethyl [2E]-3-cyano-3-(1-ethyl-1H-indol-3-yl)-2-hydrox-Ethyl [2E]-3-(1-benzyl-1H-indol-3-yl)-3-cyano-2-Ethyl [2E]-3-cyano-3-[1-(4-fluorobenzyl)-1H-indol-3- yl]-2-
Preparation of [2E]-3-cyano-3-[1-(4-fluorobenzyl)-1Hindol-2-yl]-2-hydroxyacrylic acid [IId]. A solution of
[IIc] (2.2 mmol) and 2N NaOH (4 eq) in methanol (30 ml) was stirred at room temperature for 5 h. After dilution with water the mixture was acidified with 1N HCl. The precipitate that formed was filtered off and purified by silica gel flash column chromatography (eluents petroleum ether-ethyl acetate 6:4) and then recrystallized from H 2 O/EtOH to give orange crystals. Yield=54%; mp= 101-102°C; IR (nujol) v cm -1 =1695 (C=O ester), 2200 (CN), 3330 (COOH+OH). 1 
Preparation of ethyl
Dimethylsulphate (1.2 eq) was added during 10 min, under nitrogen atmosphere, to a stirred solution of [IIc] (2 mmol) in dry acetone (8 ml) containing anhydrous potassium carbonate (1.15 eq), mantained under gentle reflux. The mixture was heated under reflux for 2 h, then cooled and filtered. Evaporation of the acetone left a residue which was purified by silica gel flash column chromatography (eluents petroleum ether-ethyl acetate 7:3) to give a yellow oil. Yield=58%; mp=oil at room temperature; IR (nujol) v cm -1 =1720 (C=O ester), 2200 (CN). 1 
Preparation of (1-alkyl-1H-indol-3-yl)acetonitriles
[5a-5c]. A suspension of crushed KOH pellets (4 eq) in DMSO (40 ml) was magnetically stirred for 5 min and then [4] was added (19 mmol). The mixture was stirred at room temperature for 45 min. Finally the appropriate alkyl bromide (1.1 eq; bromoetane for [5a], benzylbromide for [5b] or 4-fluoro-benzylbromide for [5c] was added and stirring was continued for 30 min. When reaction was complete it was quenched by the addition of water and the solution was extracted with diethyl ether. The organic layers were then washed with water, dried over Na 2 SO 4 and solvent was removed in vacuo to dryness. The residue was purified by flash chromatography (eluents petroleum etherethyl acetate 8:2) to give the desired [5a-c].
(1-ethyl-1H-indol-3-yl)acetonitrile [5a]. Yield=90%; mp=oil at room temperature; IR (nujol) v cm -1 =2200 (CN). (Jahangir et al., 1987) . Yield=50%; mp=93-95°C; IR (nujol) v cm -1 = 2235 (CN). 1 H-NMR (CDCl 3 ) δ 7.59 (d, 1H, Ar-H), 7.33-7.09 (m, 8H, Ar-H), 5.29 (s, 2H, CH 2 ), 3.83 (s, 2H, CH 2 CN). GC\MS m/z 246 (M + ).
, Ar-H), 7.29-6.95 (m+ dd, 7H, Ar-H), 5.27 (s, 2H, CH 2 ), 3.84 (s, 2H, CH 2 CN). GC\MS m/z 264 (M + ).
Preparation of 3-
(3.5 mmol) and methansulphonic acid (79 mmol) was stirred at room temperature for 15 h. Then 80% ethanol (10 ml) was added and the mixture was allowed to stir at room temperature for 3 h longer. The solution was filtered and evaporated in vacuo to dryness. The residue was purified by flash chromatography (eluents petroleum ether-ethyl acetate 1:1) and (Adam, 1993) . To a suspension of 60% NaH in mineral oil (1.0 eq) in anhydrous THF (10 ml), a solution of [7] (3.4 mmol) dissolved in anhydrous THF (5 ml) was added. The mixture was stirred at room temperature under nitrogen atmosphere for 30 min. When an internal temperature of 0°C was achieved, benzoylchloride (1 eq) was added and the mixture was stirred at the same temperature for 1 h. Then a solution of potassium tbutoxyde/t-butyl alcohol complex (2 eq) was added rapidly. After 15 h glacial acetic acid (2 eq) and water was added. The mixture was concentrated in vacuo and the solid residue purified by flash chromatography (eluents petroleum etherethyl acetate 4:6). Finally the solid was triturated with petroleum ether-diethyl ether to give a green powder. Yield=66%; mp=116-118°C. IR (nujol) v cm -1 =1630 (ketone), 3340 (OH). 
Preparation of [2Z]-3-hydroxy-1-(2-hydroxyphenyl)-3phenylprop-2-en-1-one [IV]
Preparation of 1-(2-hydroxyphenyl)ethanone [7]
. (Abilgaard et al., 1998) . A solution of [6] (1.0 eq) in anhydrous dichloromethane was stirred under nitrogen atmosphere at -30°C for 5 min.Then 1M BBr 3 solution in dichloromethane (1.05 eq) was added and the mixture was stirred at -30°C for 12 h. After additional 8 h of stirring at room temperature, the reaction was quenched by addition of methanol and washed three times with methanol. Finally solvent was removed in vacuo to dryness and the residue purified by flash chromatography (eluents petroleum ether-ethyl acetate 9:1). Yield=26%; mp=57-59°C; IR (nujol) v cm -1 =1730 (ketone), 3330 (OH). (House et al., 1968) . To a mixture of 60% NaH in mineral oil (2 eq), diethyloxalate (1 eq) and absolute ethanol (0.1 eq) in toluene (15 ml), was added [8] (12 mmol) dissolved in toluene (5 ml). The reaction was stirred at room temperature for 12 h. Then glacial acetic acid (4.5 eq) was added and the mixture was concentrated to dryness in vacuo. The residue was purified by flash chromatography (eluents petroleum ether-ethyl acetate 8:2) to give an oil. Yield=14%; mp=oil at room temperature; IR (nujol) v cm -1 =1690 (ester), 1730 (ester), 3280 (OH). 1 (1 mmol) was added to a solution of water (6 ml) and 37% HCl (3 ml). The mixture was heated at 55°C for 6-8 h under stirring. The resulting pale yellow solid was filtered and washed with acetone. (Stiles et al., 1991) 
Preparation of phenylmethylketones [10b] and [10c].
The appropriate ketone [9b] and [9c] (6.5 mmol) and anhydrous ethyl acetate (2 eq) were added to a suspension of 60% NaH in mineral oil (2 eq) in anhydrous diethyl ether (20 ml) under nitrogen atmosphere. The mixture was stirred at room temperature for 48 h (for [10b]) or at 50°C for 3 h (for [10c] ). The solution was acidified by dropwise addition of 1N HCl, then extracted with diethyl ether. Finally organic layer was washed with water, dried and concentrated in vacuo. The residue was purified by flash chromatography (eluents petroleum ether-ethyl acetate 9.5:0.5) to give a pale yellow oil. Preparation of 7-hydroxypyrido [1, . A solution of [13] (5 mmol) and diethyloxalate (2 eq), anhydrous methanol (10 ml) and sodium methoxide (4 eq, generated from sodium in methanol) in THF (10 ml) was refluxed and stirred under nitrogen atmosphere for 15 h. Then the solution was acidified with 1 N H 2 SO 4 and the yellow precipitate was filtered and recrystallized from H 2 O/EtOH. Yield=19%; mp=213-215°C; IR (nujol) v cm -1 =1645 (CO amide), 1710 (ester), 3325 (OH). 1 H-NMR (DMSO) δ 8.30 (d, 1H, Ar-H), 7.80 (d, 1H, Ar-H), 7.40-7.33 (m, 2H, Ar-H), 6.00 (s, 1H, C=CH). GC/MS m/z 213 (M + ). Anal. Calc. for C 12 H 7 NO 3 : C, 67.61; H, 3.31, N 6.57. Found: C, 67.81; H, 3.11, N 6.84.
Preparation of 1-(1H-indol-2-yl)ethanone [13].
A solution of 1.4 M methyllithium in diethyl ether (0.5 eq) was slowly added under nitrogen atmosphere to a suspension of [12] (1 eq) in anhydrous diethyl ether (30 ml) cooled at 0°C and the mixture was refluxed for 1 h. An additional 1.4 M methyllithium (0.5 eq) was added and the mixture was refluxed for 5 h. The reaction was then quenched by addition of saturated aqueous ammonium chloride, diluted with diethyl ether, and extracted with diethyl ether. Solvent was removed in vacuo and the solid residue purified by flash chromatography (eluents petroleum ether-ethyl acetate 8.5:1.5). Yield=58%; mp=151-153°C; IR (nujol) v cm -1 =1715 (ketone), 3240 (NH). -indole-2-carboxylic acid [12] . (Katritzky et al., 1985) A suspension of the ester [11] (5 mmol) in 12% KOH aqueous solution (50 ml) was refluxed for 1 h. The clear solution was poured into crushed ice and acidified with 2N HCl. The white precipitate was filtered and washed with water. Yield=93%; mp= 207-209°C; IR (nujol) v cm -1 =3260 (NH), 3840 (COOH). 1 General procedure for the preparation of isoxazolecarboxylic acids [VIIIa-VIIIf]. A mixture of the appropriate ester [15a-15f ] (1 mmol) in 12% KOH (5.2 eq) was stirred under reflux for 1 h. Then water was added and the solution was acidified with 2N HCl. The white precipitate that formed was filtered, washed with water and recrystallized from H 2 O/EtOH. (King et al., 1972) . Yield=34%; mp=181-182°C; IR (nujol) v cm -1 = 1610 (isoxazole), 1710 (COOH). 1 , 4.16; N, 11.56. Found: C, 64.70; H, 4.28; N, , 3.87; N, 9.79. Found: C, 62.90; H, 3.81; N, 9.72. 4, (Tanaka et al., 1998 (Penning et al., 1997 Methyl hydroxy (1-oxo-3,4-dihydronaphthalen-2 (Emerson et al., 1991) [17e] . A mixture of KOH (crushed pellets) (4 eq) in DMSO (18 ml) was stirred at room temperature for 5 min. 2-acethylpyrrole [7] (9.0 mmol) was added and the mixture was stirred for 45 min. After this time, 4-fluoro-benzylbromide was added (2 eq) and the reaction mixture was stirred at room temperature for a further 45 min.
Preparation of 1H
5-phenylisoxazole-3-carboxylic acid [VIIIa]
Methyl 2-hydroxy-4-(1-ethyl-1H-indol-3-yl)-4-oxo-but-
2-enoate [16c]
Methyl 2-hydroxy-4-(1-benzyl-1H-indol-3-yl)-4-oxo- but-2-enoate [16d](1H)- ylidene)acetate [16f]
Preparation of 1-[1-(4-fluorobenzyl)-1H-pyrrol-2yl]ethanone
Then reaction was quenched by addition of water and the solution was extracted three times with diethyl ether. The organic layer was washed with water and dried over Na 2 SO 4 . After evaporation of the solvent, the crude product was purified by silica gel flash chromatography (eluents petroleum ether-ethyl acetate 9:1) to give a yellow oil. Yield=94%; mp=oil at room temperature; IR (nujol) v cm -1 =1640 (ketone). 1 H-NMR (CDCl 3 ) δ 7.36-7.28 (m, 2H, Ar-H), 7.11-6.83 (m, 4H, Ar-H), 6.22-6.18 (m, 1H, Ar-H), 5.53 (s, 2H, CH 2 ), 2.41 (s, 3H, COCH 3 ). GC/MS m/z 217 (M + ). (Garrido et al., 1984) . [15e] ). Subsequently the toluene layer was decanted, the oil residue was dissolved in water, and it was washed with ethyl acetate. To this aqueous solution was added a solution of sodium tetrafluoroborate (4 eq) in water and, after cooling with ice, a yellow solid was separated. , 51.64; H, 4.60; N, 7.53. Found: C, 51.33; H, 4.42; N, 7.36 .
Preparation of 1-(1H-pyrrol-2-yl)ethanone [19]
5-(1-ethyl-1H-indol-3-yl)-3-(methoxycarbonyl)-2-
5-[1-(4-fluorobenzyl)-1H-pyrrol-2-yl]-3-(methoxycarbonyl)-2-methylisoxazol-2-ium tetrafluoroborate [21e].
Yield=52%; mp=168-170°C; IR (nujol) v cm -1 =1060 (BF 4 -), 1375 (CH 3 ), 1740 (ester). 1 , 50.78; H, 4.01; N, 6.97. Found: C, 50.89; H, 4.22; N, 7.11. 1, NO BF 4 : C, 54.39; H, 4.92; N, 4.88. Found: C, 54.25; H, 4.87; N, 4.69. Biology Materials, chemicals and enzymes. All compounds were dissolved in DMSO and the stock solutions were stored at -20°C. The γ[ 32 P]-ATP was purchased from either Amersham Biosciences or ICN. The expression systems for the wild-type IN and soluble mutant IN F185KC280S were generous gifts of Dr Robert Craigie, Laboratory of Molecular Biology, NIDDK, NIH, Bethesda, MD, USA.
Preparation of oligonucleotide substrates. The oligonucleotides 19top, 5′-GTGTGGAAAATCTCTAG-CA-3′ and 21bot, 5′-ACTGCTAGAGATTTTCCA-CAC-3′ were purchased from Norris Cancer Center Microsequencing Core Facility (University of Southern California) and purified by UV shadowing on polyacrylamide gel. To analyse the extent of strand transfer using 5′end labelled substrates, 19top was 5′-end labelled using T4 polynucleotide kinase (Epicentre, Madison, WI, USA) and γ [ 32 P]-ATP (Amersham Biosciences or ICN). The kinase was heat-inactivated and 21bot was added in 1.5-molar excess. The mixture was heated at 95°C, allowed to cool slowly to room temperature, and run through a spin 25 mini-column (USA Scientific) to separate annealed doublestranded oligonucleotide from unincorporated material.
Integrase assays. To determine the extent of strand transfer, wild-type IN was preincubated at a final concentration of 200 nM with the inhibitor in reaction buffer (50 mM NaCl, 1 mM HEPES, pH 7.5, 50 µM EDTA, 50 µM dithiothreitol, 10% glycerol (w/v), 7.5 mM MnCl 2 , 0.1 mg/ml bovine serum albumin, 10 mM 2-mercaptoethanol, 10% dimethyl sulphoxide, and 25 mM MOPS, pH 7.2) at 30°C for 30 min. Then, 20 nM of the 5′-end 32 P-labelled linear oligonucleotide substrate was added, and incubation was continued for an additional 1 h. Reactions were quenched by the addition of an equal volume (16 µl) of loading dye (98% deionized formamide, 10 mM EDTA, 0.025% xylene cyanol and 0.025% bromophenol blue). An aliquot (5 µl) was electrophoresed on a denaturing 20% polyacrylamide gel (0.09 M tris-borate pH 8.3, 2 mM EDTA, 20% acrylamide, 8M urea).
Gels were dried, exposed in a PhosphorImager cassette, and analysed using a Typhoon 8610 Variable Mode Imager (Amersham Biosciences) and quantitated using ImageQuant 5.2. Percent inhibition (% I) was calculated using the following equation:
where C, N and D are the fractions of 21-mer substrate converted to strand transfer products for DNA alone, DNA plus IN, and IN plus drug, respectively. The IC 50 values were determined by plotting the logarithm of drug concentration versus percent inhibition to obtain concentration that produced 50% inhibition.
Molecular modelling
Model compounds [IId] and [VIa] were constructed with standard bond lengths and angles from the fragment database with MacroModel 6.0 (1997) using a Silicon Graphics O2 workstation running on IRIX 6.3. Sybyl 6.2 (2001) was used as graphic platform. The atomic charges were assigned using the Gasteiger-Marsili method (Gasteiger et al., 1980) . Minimization of structures was performed with the MacroModel/BachMin 6.0 program using the Amber force field. Extensive conformational search was carried out using the Monte Carlo/Energy minimization (Chang et al., 1989) for all the compounds considered in the study (Ei-Emin <5 kcal/mol, energy difference between the generated conformation and the current minimum). Representative minimum energy conformations of each compounds were optimized using the ab initio quantum chemistry program Gaussian 98 with UHF/6-31* basis set. Docking calculations were performed on HP Exemplar Parallel Server V2200 running HP UX 11.0.
Subunit A of IN core domain in complex with 1-(5chloroindol-3-yl)-3-hydroxy-3-(2H-tetrazol-5-yl-propenone) (5CITEP; PDB 1QS4) was used for all docking studies. The missing residues at positions 141-144 in this subunit were incorporated from monomer B of the IN structure PDB 1BIS after superimposition of the backbones of residues 135-140 and 145-150, as previously reported . Docking was performed with AutoDock version 3.05 (Morris et al., 1998) using the new empirical free energy function and the Lamarckian protocol (Morris et al., 1996) . Mass-centered grid maps were generated with 80 grid points for every direction and with 0.375 Angstroms spacing by the AutoGrid program for the whole protein target. Random starting position on the entire protein surface, random orientations and torsions were used for the ligands. The distance-dependent dieletric permittivity of Mehler and Solmajer was used for the calculation of the electrostatic grid-maps. Fifty independent docking runs were carried out for each ligands. The cluster analyses were computed with a cluster tolerance by less than 1.5 Å in positional root-mean-square deviation. was commercially available and [3b] and [3c] were prepared as previously described (Sarges et al., 1989) . Interestingly, the disubstituted 2-oxindole-ylidene derivatives, generated from the enolic form of C-2 carbonyl, were stereoselectively obtained in the Z-configuration. This assumption was supported by the marked deshielding effect of the H-4 proton of the oxindole nucleus due to the carboxylate group located on the ylidene moiety, which forms a 'transoid system' (Long et al., 1978 , Autrey et al., 1967 with the oxindole carbonyl (Figure 4, A) . These observations were unambigously confirmed on the basis of NOE difference and NOESY experiments data, which showed NOE correlations between H-4 and the methyl ester group of [Ia-Ic] (Figure 4-B) .
Results
Chemistry
The synthetic route to obtain sequentially the 3-ciano-2-ketoesters [IIa-IIc], the correspondent acid [IId] (from [IIc]) and the 3-hydroxy-1H-pyrrole-2,5-dione derivative [III] (from [IIa]) is shown in Figure 5 revealed the presence of enolic form in solution with consequent formation of a double bond. In order to establish the exact configuration of [IIa-IId], we methylated the enol group of [IIc] to obtain its methoxy derivative [IIe] ( Figure 5-B) , which could be suitable for NMR investigations. NOE experiments conducted using this model compound showed an E-configuration of the cyanoketo ester moiety and demonstrated the stereoselectivity of the above-mentioned reaction ( Figure 5-B ). The ester [IIa] was then converted into a pyrrole ring system, [III] ( Figure  5 -A) by treating with methanesulphonic acid followed by quenching in ethanol (Rooney et al., 1983) . Alkylation of [4] with an appropriate alkylbromide and solid KOH in DMSO gave the intermediate N-alkylindoles [5a-5c] ( Figure 5-A) .
The β-diketone [IV] was synthesized by an intramolecular acyl transfer reaction (Baker-Venkataraman-like reaction) by reacting the 2-hydroxyacetophenone [7] with benzoylchloride using NaH in THF and t-ButOH / t-ButOK complex (Kraus et al., 1984) . Deprotection of the methoxy group of [6] to give the intermediate [7] was carried out with boron tribromide in dichloromethane at -40°C ( Figure 6-A) .
Claisen condensation of ethyl phenylacetate [8] with diethyloxalate and NaH dissolved in toluene (House et al., 1968 ) afforded the diester [V] in the enolic form ( Figure  6-B) .
The 6-aryl-2,4,6-trioxohexanoic esters [VIa-VIc] were obtained by treatment of benzoylacetones [10a-10c] with dimethyloxalate in the presence of magnesium methyl carbonate (Stiles reagent; Stiles et al., 1991) (Figure 7-A) .
The tricycle [VII] was prepared following a tandemreaction through a direct oxalylation of 2-acetylindole [13] using 4 eq of sodium methoxide under reflux conditions for 15 h to obtain β-diketo ester [14] (intermediated not isolated) as a first step. These reaction conditions favoured an intramolecular amination (second step) to give the desired [VII] (Figure 7-B (Figures 8-A,B) . These intermediates were easily obtained by oxalylation of the aryl(heteroaryl)-ketones [17a-17f ], [18] in the presence of sodium methoxide dissolved in CH 3 OH under reflux conditions. Finally, the methylderivative [VIIIg] was prepared by treating 2-acetyl-3,4dihydronaphthalen-1(2H)-one [16g] with hydroxylamine hydrochloride (Figure 8-B or prepared through a new synthesis ([17e], Figure 9 -A).
Several chemical aspects of reaction of aryl and heteroaryl β-diketoalkanoates with hydroxylamine hydrochloride, as well as methods to distinguish regioisomers, were recently described (Battaglia et al. 1970; Baumstark et al., 1980; Sechi et al., 2003) . Interestingly, we observed that compounds [15a-15f ] and [VIIIg] were obtained as single regioisomers. As far as the regiochemistry is concerned, the only regioisomers obtained from the above-mentioned reaction were consistent with the structure of 5-aryl(heteroaryl)-isoxazole-3-carboxylic acids [VIIIa-VIIIf ] and 3-methyl-4,5-dithydronaphtho [1,2c] isoxazole [VIIIg]. The regioselectivity observed under our reaction condition was postulated on the basis of previous studies (Sechi et al., 2003) 
Molecular modelling
Several computational docking studies using the IN-5CITEP co-crystal structure (Goldgur et al., 1999) have recently been reported Ni et al., 2001; Buolamwini et al., 2002; Barreca et al., 2003; Schames et al., 2004) . Unfortunately, many details of the protein-ligand interaction remain uncertain because the binding modes are significantly influenced by the crystal packing effect. As a 3D structure of the full-length IN complexed with DNA is not available, this is the only known structure that provided sufficient information of the IN active site in the presence of a bound inhibitor (Parril, 2003) . It is also important to note that this model provides information of the mode of binding a ligand in an early step of the integration processes, in particular before the formation of the complex with donor DNA substrate. In order to investigate the binding-site of the most active compounds, [IId] and [VIa], we performed computational docking studies on the IN-5CITEP complex (PDB 1QS4) as described . Based on the structure of (Kees et al., 1995) under physiological conditions, we used its deprotonated form for docking studies. These compounds were subsequently subjected to quantum mechanics calculations.
The results of clustered docking runs with the most favourable free binding energy for [IId] and [VIa] are given in Table 2 . Graphical representations of top-ranking binding modes obtained for these ligands showing the important residues involved in binding are depicted in Figure 10 . Compound [IId] was found to bind to D64 through the hydroxy group in both clusters, and it also established a coordination bond with Mg 2+ by a combination of hydroxy and carboxylate groups. As shown in Figure  10 , superimposition of the most energetically favourable conformers [IId 1-2 ] indicated the same bound conformation inside the active site. The triketo ester [VIa] formed H-bonds with D64 and established a coordination bond with Mg 2+ ion through an hydroxy-keto system of the triketo moiety. Also of interest, the top and second conformers considerably overlap [VId 1-2 ] with regard to direction, but have the opposite orientation ( Figure 10 ). However, they displayed the same mode of binding and adopted a similar position on the IN active site.
On the basis of these results, the inhibitory potency of compounds [IId] and [VIa] can be explained by their unique arrangement in the IN active site. In particular, the interactions with Mg 2+ cation and D64 are important functions for the activity of IN (Ellison et al., 1994; Kulkosky et al., 1992; Hazuda et al., 1997; Chiu et al., 2004) , represent the most important features.
Finally, the estimated free binding energy values (∆G bind ) of the docked positions, expressed in kcal/mol, indicated favourable interactions and tight binding with key aminoacid residues on the active site of IN. In particular [IId] displayed better energy results than [VIa], which agree with their respective potency against IN.
Conclusions
The results of this study suggest that both the cyanoketo acid and the triketo ester moieties are important structural features required for the anti-HIV-1 IN activity. From the 10 10/6 -6.00 D64, C65, S119, N120 *Total number of clusters. † Number of distinct conformational clusters found out of 50 runs / number of multi-member conformational clusters. ‡ Estimated free binding energy (kcal/mol). β-diketo acid inhibitors of HIV-1 integrase structural point of view, the triketo ester fragment of compound [VIa] may be considered formally an homologue of the diketo acid functionality, while the cyanoketo acid side chain of compound [IId] constitutes a novel potential pharmacophore and a bioisostere of the diketo acid functionality. Chelation of metal co-factors have been implicated for diketo acids-based inhibitors (Grobler et al., 2002; Long et al., 2004; Marchand et al., 2003; Maurin et al., 2003) and proposed for some other related classes of inhibitors Zhao et., 1997 , Ouali et al., 2000 . In this context the lack of activity demonstrated by the isoxazole derivatives supports these assumptions.
